CD13 - Overview: CD13 Immunostain, Technical Component Only
Marker of myeloid lineage
CD79 - Overview: CD79a Immunostain, Technical Component Only
Phenotyping leukemias and lymphomas
AMYPI - Overview: Amyloid P (SAP) Immunostain, Technical Component Only
Identification of amyloid deposits in tissue
CD2 - Overview: CD2 Immunostain, Technical Component Only
Determining T-cell lineage
MHPRP - Overview: Metamycoplasma hominis, Molecular Detection, PCR, Plasma
Rapid, sensitive, and specific identification of Metamycoplasma hominis from plasma This test is not intended for medicolegal use.
P63 - Overview: p63 Immunostain, Technical Component Only
Aiding in identifying squamous, urothelial, or myoepithelial differentiation in tumors
SYNAP - Overview: Synaptophysin (SYNAPTO) Immunostain, Technical Component Only
Identification of neuronal tumors and tumors with neuroendocrine differentiation
WEEPC - Overview: Western Equine Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid
Aiding in the diagnosis of Western equine encephalitis using spinal fluid specimens
TSH - Overview: Thyroid-Stimulating Hormone (TSH), Beta Immunostain, Technical Component Only
Part of a panel of immunostains used in the classification of pituitary adenomas
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...